| 2 | 1/1 | 返回列表 |
| 查看: 337 | 回復(fù): 1 | |||
| 本帖產(chǎn)生 1 個(gè) 翻譯EPI ,點(diǎn)擊這里進(jìn)行查看 | |||
[求助]
求翻譯一句話
|
|||
| 傳統(tǒng)芯片篩查或驗(yàn)證往往集中在細(xì)胞上進(jìn)行,脫離了臨床,本研究充分利用前期建立的臨床樣本庫,分階段逐步進(jìn)行篩選驗(yàn)證與CLM相關(guān)的lncRNA,更有意義。 |
榮譽(yù)版主 (知名作家)
快樂島、布吉島島主
| Traditional chip screening or validation focuses on cells without clinical trials. This study took full advantages of preliminary data from clinical samples, and shown greater significance in screening and verifying CLM related IncRNA. |
| 2 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|